drugset / Trial / NCT03777163
Safety and Immunogenicity of the Butantan Institute Influenza Vaccine Compared to Sanofi Pasteur Influenza Vaccine
RandomizedParallel-groupQuadruple-blindPrevention
Summary
The overall aim of this study is to evaluate the safety and immunogenicity of Butantan Institute Trivalent Seasonal Influenza Vaccine in comparison with the Sanofi Trivalent Seasonal Influenza Vaccine.
Timeline
- Start
- 2019-04-22
- Primary completion
- 2020-01-15
- Completion
- 2020-03-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Butantan Institute Trivalent Seasonal Influenza Vaccine | Vaccine | 0.5 ml | Intramuscular |
| Subject | Sanofi Trivalent Seasonal Influenza Vaccine | Vaccine | 0.5 ml | Intramuscular |